We are live on ! Find out more
SMTI icon

Sanara MedTech
SMTI

20 hedge funds and large institutions have $17.2M invested in Sanara MedTech in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

231% more capital invested

Capital invested by funds: $5.2M → $17.2M (+$12M)

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

33% more funds holding

Funds holding: 15 → 20 (+5)

5.85% more ownership

Funds ownership: 1.66% → 7.51% (+5.8%)

Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
5
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$7.8M
2
MS
Maven Securities
Jersey
+$2.43M
3
LCM
Laurion Capital Management
New York
+$1.68M
4
MIM
Monashee Investment Management
Massachusetts
+$1.53M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$622K

Top Sellers

Rank Fund Capital Flow
1
ECM
ExodusPoint Capital Management
New York
-$515K
2
CWM
CCG Wealth Management
California
-$269K
3
SMG
Smart Money Group
Texas
-$250K
4
AWA
Arete Wealth Advisors
Illinois
-$247K
5
UBS Group
UBS Group
Switzerland
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
OSAM
26
O'Shaughnessy Asset Management
Connecticut
– -$243 -7 -41%
1
2

SMTI Hedge Fund Activity: Q1 2021 in Review

20 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q1 2021, worth a combined $17.2M — up 231% from $5.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new SMTI positions and 6 closed out — a net gain of 5 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Opaleye Management, opening a new position worth an estimated $7.8M. The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $515K sold.

  • 20 institutional investors held Sanara MedTech (SMTI) as of Q1 2021, up from 15 in Q4 2020.
  • Funds reported $17.2M of Sanara MedTech stock for Q1 2021, up 231% quarter-over-quarter.
  • 11 funds opened new Sanara MedTech positions in Q1 2021 and 6 closed out, a net change of +5 holders.
  • The largest Sanara MedTech buyer in Q1 2021 was Opaleye Management, an estimated $7.8M added.
  • The largest Sanara MedTech seller in Q1 2021 was ExodusPoint Capital Management, an estimated $515K sold.

Based on aggregated 13F filings for Q1 2021.